Veterinary Services Market Size to Reach USD 247.32 Billion by 2035 | SNS Insider

The investable takeaway is not broad "pet care" beta; it is a shift in mix toward higher-margin, more recurring spend. Diagnostics and animal-health platform companies with pricing power should capture disproportionate value because a bigger share of visits will be reimbursed, medically justified, and test-intensive. That favors IDXX and ZTS over clinic-level operators, where labor inflation, technician scarcity, and capex needs can soak up much of the market growth.

The second-order loser is the low-end discretionary pet ecosystem: if owners reallocate wallet share from products to treatment, names tied to consumables and convenience retail can lag even while total pet spend rises. TRUP is interesting as a picks-and-shovels beneficiary, but only if claims inflation stays contained; otherwise premium hikes can slow adoption and cap growth. The market may be underestimating how much of the upside accrues to insurers, diagnostics, and specialty procedures versus "vet services" as a generic label.

This is a 6-18 month structural theme, not a next-week catalyst. Near term, there may be little to trade unless earnings or underwriting data confirm unit growth, mix, and loss-ratio trends. The thesis is falsified if consumer weakness causes visit deferrals, if pet insurance loss ratios force material price increases, or if diagnostics volume growth slows despite rising market size assumptions.